Abstract
Aim/Purpuse: To evaluate our experience of 19 patients of lymphangioma who were treated by intralesional Bleomycin.Materials and Methods: Nineteen patients of lymphangioma aged between 16 days to 11 years were managed in the department. The male-female ratio was of 2:1. Commonest sites were in the neck (58%) followed by axilla (21%). The patients were treated by intralesional bleomycin injection. Bleomycin was given at a dose not exceeding 0.5 unit/kg/dose at interval of 2 weeks. Reduction in size of the mass was noted in between 2 weeks to 16 weeks and number of injections required for each patient varied from 1 to 6. Follow up ranged from 1– 7 Year.Result: In injection group, significant reduction of mass was noted in 84% (n=l6) and 57% (n=11) of them showed complete disappearance. No serious complications were noted in any patient.Conclusion: Our experience showed that Bleomycin in aqueous solution is a good sclcrosing agent in the management of lymphangioma.
Similar content being viewed by others
References
Kennedy TL, Whitaker M, Pellitteri P, Wood WE.Cystic hygroma/ lymphangioma: a rational approach to management Laryngoscope.2001;111:1929–37.
Chappuis JP.Current aspects of cystic lymphangioma in the neck Arch Pediatr. 1994;1(2):186–92
Naidu SI, McCalla MR.Lymphatic malformations of the head and neck in adults: a case report and review of the literature.Ann Otol Rhinol Laryngol. 2004;113:218–22.
Kennedy TL.Cystic hygroma-lymphangioma: a rare and still unclear entity Laryngoscope.1989:99:1–10.
Ninh TN.Cystic hygroma in children: a report of 126 cases.J Pediatr Surg 1974;9:191–195.
Chait D.Management of cystic hygromas.Surg Gynecol Obstet 1974;139:55–58.
Charabi B, Bretlau P, Bille M, Holmelund M.Cystic hygroma of the head and neck—a long-term follow-up of 44 cases Acta Otolaryngol Suppl. 2000;543:248–50.
Selz PA.Laryngeal lymphangioma: a case report of an uncommon entity.Otolaryngol Head Neck Surg 1998;118:382–384.
Rothenberg SR.Use of argon beam ablation and sclerotherapy in the treatment of a case of life-threatening total abdominal lymphangiomatosis.J Pediatr Surg 1994;29:322–323.
Dubois J.Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein.Radiology 1997;204:651–654.
Won JH, Kim BM, Kim CH, Park SW, Kim MD.Percutaneous sclerotherapy of lymphangiomas with acetic acid.J Vasc Interv Radiol. 2004;15:595–600
Castanon M, Margarit J, Carrasco R, Vancells M, Albert A, Morales L.Long-term follow-up of nineteen cystic lymphangiomas treated with fibrin sealant.J Pediatr Surg. 1999;34:1276–9.
Farmand M, Kuttenberger JJ.A new therapeutic concept for the treatment of cystic hygroma.Oral Surg Oral Med Oral Pathol Oral Radiol Endod.1996;81:389–95.
Ikeda K.Massive infiltrating cystic hygroma of the neck in infancy with special reference to bleomycin therapy.Z Kinderchir 1977:20:227–236.
Yura J. Bleomycin treatment for cystic hygroma in children.Arch Jpn Chir 1977;46:607–614.
Orrford J. Bleomycin therapy for cystic hygroma.J Pediatr Surg 1995;30:1282–1287.
Tanaka K, Inomata Y, Utsunomiya H, et al:Sclerosing Therapy with Bleomycin emulsion for Lymphangioma in children:Pediatric Surg. Int. 1990:5:270–273.
Tanigawa N, Shimomatsuya T, Takahashi K, Inomata Y, Tanaka K, Satomura K, Hikasa Y, Hashida M, Muranishi S, Sezaki H.Treatment of cystic hygroma and lymphangioma with the use of bleomycin fat emulsion.Cancer.1987;60:741–9.
Okada A, Kubota A, Fukuzawa M, Imura K, Kamata S.Injection of Bleomycin as a primary therapy of cystic Lymphangioma.J Paediatr Surg 1992;27:440–443.
Otiga S, Tsuto T, Takahashi T:Intracystic injection of OK 432. A new sclerosing therapy for cystic hygroma in children.Br J Surg 1989;74:690–691.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rawat, J.D., Sinha, S.K., Kanojia, R.P. et al. Non surgical management of cystic lymphangioma. Indian J Otolaryngol Head Neck Surg 58, 355–357 (2006). https://doi.org/10.1007/BF03049593
Issue Date:
DOI: https://doi.org/10.1007/BF03049593